个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS OF A RANDOMISED TRIAL EVALUATING THE EFFECT OF A SMART PHONE BASED PATIENT SUPPORT TOOL ON TREATMENT DURATION IN PATIENTS PRESCRIBED ROSUVASTATIN IN CHINA (EHELP CHINA)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Karlson, B. W.[2,11] * ; Jornten-Karlsson, M.[2] ; Xu, Y.[3] ; Guo, J.[4] ; Li, J.[5,9] ; Mei, X.[6] ; Han, L.[7] ; Wang, J.[8] ; Li, J.[5,9] ; Shen, Z.[10] ; Ryden, A.[2] ; Ahlqvist, M.[2] ; Sunden, M.[2] ; Du, Xin[1] ; Ma, C.[12] ;
机构： [1]Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China [2]AstraZeneca Gothenburg, Molndal, Sweden [3]Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China [4]Capital Med Univ, Beijing Luhe Hosp, Beijing, Peoples R China [5]Pla 254 Hosp, Tianjin, Peoples R China [6]Zhongshan Hosp, Chengdu, Sichuan, Peoples R China [7]Capital Med Univ, Fuxing Hosp, Beijing, Peoples R China [8]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China [9]Gen Hosp Pla Beijing, Beijing, Peoples R China [10]Shanghai Jiao Tong Univ, Sch Med, Tong Ren Hosp, Shanghai, Peoples R China [11]Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden [12]Capital Med Univ, Anzhen Hosp, Beijing, Peoples R China
出处：
DOI： 10.1016/j.atherosclerosis.2017.06.803
ISSN：

关键词： Adherence statins dyslipidaemia mobile health

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2016]版：
大类 | 2 区 医学
小类 | 2 区 外周血管病
最新[2023]版：
大类 | 2 区 医学
小类 | 2 区 外周血管病 3 区 心脏和心血管系统
JCR分区：
出版当年[2015]版：
Q1 PERIPHERAL VASCULAR DISEASE
最新[2023]版：
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 PERIPHERAL VASCULAR DISEASE

影响因子： 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者：
第一作者机构： [2]AstraZeneca Gothenburg, Molndal, Sweden [11]Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
推荐引用方式(GB/T 7714)：
Karlson B. W.,Jornten-Karlsson M.,Xu Y.,et al.RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS OF A RANDOMISED TRIAL EVALUATING THE EFFECT OF A SMART PHONE BASED PATIENT SUPPORT TOOL ON TREATMENT DURATION IN PATIENTS PRESCRIBED ROSUVASTATIN IN CHINA (EHELP CHINA)[J].ATHEROSCLEROSIS.2017,263:E247-E248.doi:10.1016/j.atherosclerosis.2017.06.803.
APA：
Karlson, B. W.,Jornten-Karlsson, M.,Xu, Y.,Guo, J.,Li, J....&Ma, C..(2017).RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS OF A RANDOMISED TRIAL EVALUATING THE EFFECT OF A SMART PHONE BASED PATIENT SUPPORT TOOL ON TREATMENT DURATION IN PATIENTS PRESCRIBED ROSUVASTATIN IN CHINA (EHELP CHINA).ATHEROSCLEROSIS,263,
MLA：
Karlson, B. W.,et al."RATIONALE, DESIGN, AND BASELINE CHARACTERISTICS OF A RANDOMISED TRIAL EVALUATING THE EFFECT OF A SMART PHONE BASED PATIENT SUPPORT TOOL ON TREATMENT DURATION IN PATIENTS PRESCRIBED ROSUVASTATIN IN CHINA (EHELP CHINA)".ATHEROSCLEROSIS 263.(2017):E247-E248

相关文献

[1]Diagnostic Accuracy of Mobile Health-Based Audiometry for the Screening of Hearing Loss in Adults: A Systematic Review and Meta-Analysis [2]Current challenges with adherence to pharmacotherapy in allergic rhinitis [3]Adherence in allergen immunotherapy: Current situation and future implications [4]Asthma treatment adherence and related factors in Shanghai, China [5]Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study [6]Biological Actions, Implications, and Cautions of Statins Therapy in COVID-19 [7]智能移动健康宣教系统在视网膜脱离日间手术病人围术期的应用 [8]如何提高青光眼患者的用药依从性 [9]他汀类药物的抗心律失常作用 [10]他汀导致肝酶升高63例回顾性分析

资源点击量：21169 今日访问量：0 总访问量：1219 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持：重庆聚合科技有限公司 地址：北京市东城区东交民巷1号(100730)